Improvements in insulin sensitivity with tirzepatide versus semaglutide

被引：0
|
作者：
Kahl, S. [1 ]
机构：
[1] Heinrich Heine Univ, Inst Klin Diabetol, Deutsch Diabet Zentrum, Leibniz Zentrum Diabet Forsch, Hennekamp 65, D-40225 Dusseldorf, Germany
来源：
DIABETOLOGIE | 2025年 / 21卷 / 02期
关键词：
D O I：
10.1007/s11428-025-01294-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：221 / 222
页数：2
相关论文
共 50 条
  • [1] Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis
    Mather, Kieren J.
    Mari, Andrea
    Weerakkody, Govinda
    Heise, Tim
    Devries, J. Hans
    Urva, Shweta
    Coskun, Tamer
    Milicevic, Zvonko
    Haupt, Axel
    Thomas, Melissa K.
    DIABETES OBESITY & METABOLISM, 2025, 27 (03): : 1507 - 1514
  • [2] Add-on value of tirzepatide versus semaglutide
    Scheen, Andre J.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (06): : 377 - 378
  • [3] Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test
    Mather, Kieren J.
    Mari, Andrea
    Heise, Tim
    DeVries, J. Hans
    Hua, Ming
    Urva, Shweta
    Coskun, Tamer
    Haupt, Axel
    Heine, Robert J.
    Pratt, Edward
    Thomas, Melissa K.
    Milicevic, Zvonko
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (12): : 3046 - 3054
  • [4] Tirzepatide versus Semaglutide Once Weekly in Type 2 Diabetes
    Frias, Juan P.
    Lando, Laura Fernandez
    Brown, Katelyn
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (07):
  • [5] Tirzepatide improved markers of islet cell function and insulin sensitivity compared to semaglutide in people with type 2 diabetes
    Brown, K.
    Lando, L. Fernandez
    Bergman, B.
    Thomas, M. K.
    Liu, B.
    Lee, C.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S309 - S309
  • [6] Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
    Frias, Juan P.
    Davies, Melanie J.
    Rosenstock, Julio
    Manghi, Federico C. Perez
    Lando, Laura Fernandez
    Bergman, Brandon K.
    Liu, Bing
    Cui, Xuewei
    Brown, Katelyn
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (06): : 503 - 515
  • [7] 5-Year simulation of diabetes-related complications in people treated with tirzepatide or semaglutide versus insulin glargine
    Niu, Shu
    Alkhuzam, Khalid A.
    Guan, Dawei
    Jiao, Tianze
    Shi, Lizheng
    Fonseca, Vivian
    Laiteerapong, Neda
    Ali, Mohammed K.
    Schatz, Desmond A.
    Guo, Jingchuan
    Shao, Hui
    DIABETES OBESITY & METABOLISM, 2024, 26 (02): : 463 - 472
  • [8] Comparison of tirzepatide versus semaglutide regarding mean change in glycated hemoglobin levels
    Heinitz, S.
    DIABETOLOGE, 2022, 18 (02): : 205 - 206
  • [9] Efficacy of semaglutide and tirzepatide by insulin delivery in overweight and obese adults with type 1 diabetes
    Snell-Bergeon, J.
    Dong, F.
    Kaur, G.
    Renner, D.
    Akturk, H.
    Garg, S.
    DIABETOLOGIA, 2024, 67 : S128 - S128
  • [10] Tirzepatide versus Semaglutide 2.4 mg for People with Obesity or Overweight and Type 2 Diabetes
    Hankosky, Emily
    Brumm, Julia Fraseur
    Malik, Raleigh
    Niemeyer, Anthony
    Wang, Fangyu
    Zhang, Xiaotian Michelle
    He, Xuanyao
    OBESITY, 2023, 31 : 83 - 84
12345